T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.42B |
| 2 |
Wynn Resorts
WYNN
|
+$992M |
| 3 |
Eli Lilly
LLY
|
+$964M |
| 4 |
Visa
V
|
+$700M |
| 5 |
American Airlines Group
AAL
|
+$626M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.24B |
| 2 |
Dollar Tree
DLTR
|
+$1.13B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.03B |
| 4 |
Gilead Sciences
GILD
|
+$792M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$788M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.45% |
| 2 | Consumer Discretionary | 13.78% |
| 3 | Financials | 12.98% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Franco-Nevada
FNV
$44.6B
| $652M | 0.14% |
13,263,138
+1,653,155
| +14% | +$91.9M |
|
|
RDS.B
177
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $651M | 0.14% |
8,224,961
+800,671
| +11% | +$67.5M |
|
178
Hilton Worldwide
HLT
$72.2B
| $638M | 0.14% |
8,632,279
+816,766
| +10% | +$60.7M |
|
179
Gartner
IT
$11.6B
| $624M | 0.14% |
8,487,144
-362,591
| -4% | -$26.3M |
|
180
Bunge Global
BG
$21.7B
| $620M | 0.14% |
7,363,286
+1,082,851
| +17% | +$87.4M |
|
181
Factset
FDS
$10.2B
| $619M | 0.14% |
5,094,262
+39,760
| +0.8% | +$4.91M |
|
182
Coca-Cola
KO
$376B
| $614M | 0.13% |
14,398,395
+142,749
| +1% | +$5.9M |
|
183
Xylem
XYL
$28.1B
| $612M | 0.13% |
17,239,409
+932,351
| +6% | +$34.6M |
|
184
Bath & Body Works
BBWI
$3.76B
| $605M | 0.13% |
11,174,098
-1,135,270
| -9% | -$57.1M |
|
|
AET
185
DELISTED
Aetna Inc
AET
| $600M | 0.13% |
7,407,120
+411,347
| +6% | +$33.5M |
|
186
Motorola Solutions
MSI
$77B
| $595M | 0.13% |
9,397,287
+157,959
| +2% | +$9.93M |
|
187
Blackrock
BLK
$183B
| $592M | 0.13% |
1,803,153
-8,508
| -0.5% | -$2.74M |
|
|
AVP
188
DELISTED
Avon Products, Inc.
AVP
| $592M | 0.13% |
46,954,563
-1,566,656
| -3% | -$21.5M |
|
189
Mattel
MAT
$4.25B
| $589M | 0.13% |
19,228,198
-239,689
| -1% | -$8.48M |
|
190
Elevance Health
ELV
$86.4B
| $588M | 0.13% |
4,916,246
+802,496
| +20% | +$92M |
|
191
HCA Healthcare
HCA
$89.2B
| $581M | 0.13% |
8,233,199
+2,709,071
| +49% | +$179M |
|
192
Progressive
PGR
$121B
| $579M | 0.13% |
22,897,536
+940,220
| +4% | +$23.2M |
|
193
Mondelez International
MDLZ
$81.1B
| $575M | 0.13% |
16,786,699
-478,443
| -3% | -$17.4M |
|
194
Harley-Davidson
HOG
$2.9B
| $569M | 0.12% |
9,770,880
-1,374,375
| -12% | -$87.9M |
|
195
Berkshire Hathaway Class B
BRK.B
$1.09T
| $566M | 0.12% |
4,094,634
+159,019
| +4% | +$21.2M |
|
|
STI
196
DELISTED
SunTrust Banks, Inc.
STI
| $563M | 0.12% |
14,795,552
-1,021,704
| -6% | -$39.4M |
|
197
IDEX
IEX
$17.6B
| $561M | 0.12% |
7,749,580
+48,350
| +0.6% | +$3.73M |
|
|
WBA
198
DELISTED
Walgreens Boots Alliance
WBA
| $554M | 0.12% |
9,347,535
+2,641,225
| +39% | +$173M |
|
199
American Electric Power
AEP
$68.3B
| $548M | 0.12% |
10,489,633
+1,029,688
| +11% | +$54.4M |
|
200
Stratasys
SSYS
$780M
| $547M | 0.12% |
4,529,686
-782,338
| -15% | -$88.4M |
|
Similar funds
T. Rowe Price Associates's Q3 2014 Portfolio in Review
As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
- T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
- T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
- T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.
Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.